nobody
nothing

2019-08-30 11:29
(1930 d 04:27 ago)

Posting: # 20530
Views: 2,391
 

 BE in hepatic impairment? [BE/BA News]

Post reply
Hello again!

Today I have to read this here:

https://www.fdanews.com/articles/192544-persion-petitions-fda-to-raise-the-safety-bar-for-extended-release-opioid

But the originator found differences in PK in mild/moderate hepatic impairment not worth any dose adjustment according to the current label and the differences as outlined in the FDA AssRep are unimpressive. I'm trying to figure out a formulation-related influence of hepatic function on BA/BE...

Lawyers looking for some work? How low can you go? Is that state-of-the-art in 2019?
—
Kindest regards, nobody
 
UA Flag
Activity
 Admin contact
23,336 posts in 4,902 threads, 1,666 registered users;
40 visitors (1 registered, 39 guests [including 11 identified bots]).
Forum time: 14:56 CET (Europe/Vienna)

I’m all in favor of the democratic principle
that one idiot is as good as one genius, but I draw the line
when someone takes the next step and concludes
that two idiots are better than one genius.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5